Literature DB >> 21467839

Frontier of epilepsy research - mTOR signaling pathway.

Chang Hoon Cho1.   

Abstract

Studies of epilepsy have mainly focused on the membrane proteins that control neuronal excitability. Recently, attention has been shifting to intracellular proteins and their interactions, signaling cascades and feedback regulation as they relate to epilepsy. The mTOR (mammalian target of rapamycin) signal transduction pathway, especially, has been suggested to play an important role in this regard. These pathways are involved in major physiological processes as well as in numerous pathological conditions. Here, involvement of the mTOR pathway in epilepsy will be reviewed by presenting; an overview of the pathway, a brief description of key signaling molecules, a summary of independent reports and possible implications of abnormalities of those molecules in epilepsy, a discussion of the lack of experimental data, and questions raised for the understanding its epileptogenic mechanism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21467839      PMCID: PMC3104248          DOI: 10.3858/emm.2011.43.5.032

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  599 in total

1.  Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy.

Authors:  Nao Hosokawa; Taichi Hara; Takeshi Kaizuka; Chieko Kishi; Akito Takamura; Yutaka Miura; Shun-ichiro Iemura; Tohru Natsume; Kenji Takehana; Naoyuki Yamada; Jun-Lin Guan; Noriko Oshiro; Noboru Mizushima
Journal:  Mol Biol Cell       Date:  2009-02-11       Impact factor: 4.138

2.  Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy.

Authors:  Katja Kobow; Ina Jeske; Michelle Hildebrandt; Jan Hauke; Eric Hahnen; Rolf Buslei; Michael Buchfelder; Daniel Weigel; Hermann Stefan; Burkhard Kasper; Elisabeth Pauli; Ingmar Blümcke
Journal:  J Neuropathol Exp Neurol       Date:  2009-04       Impact factor: 3.685

3.  ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery.

Authors:  Chang Hwa Jung; Chang Bong Jun; Seung-Hyun Ro; Young-Mi Kim; Neil Michael Otto; Jing Cao; Mondira Kundu; Do-Hyung Kim
Journal:  Mol Biol Cell       Date:  2009-02-18       Impact factor: 4.138

4.  Increased STAT-3 and synchronous activation of Raf-1-MEK-1-MAPK, and phosphatidylinositol 3-Kinase-Akt-mTOR pathways in atypical and anaplastic meningiomas.

Authors:  Mahlon D Johnson; Mary O'Connell; Fran Vito; Robert S Bakos
Journal:  J Neurooncol       Date:  2008-11-26       Impact factor: 4.130

5.  An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.

Authors:  Carson C Thoreen; Seong A Kang; Jae Won Chang; Qingsong Liu; Jianming Zhang; Yi Gao; Laurie J Reichling; Taebo Sim; David M Sabatini; Nathanael S Gray
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

6.  Rapamycin reduces seizure frequency in tuberous sclerosis complex.

Authors:  Jennifer Muncy; Ian J Butler; Mary Kay Koenig
Journal:  J Child Neurol       Date:  2009-01-16       Impact factor: 1.987

7.  TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2.

Authors:  Jeremy Copp; Gerard Manning; Tony Hunter
Journal:  Cancer Res       Date:  2009-02-24       Impact factor: 12.701

Review 8.  Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms.

Authors:  E A Dunlop; A R Tee
Journal:  Cell Signal       Date:  2009-01-08       Impact factor: 4.315

9.  Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.

Authors:  Morris E Feldman; Beth Apsel; Aino Uotila; Robbie Loewith; Zachary A Knight; Davide Ruggero; Kevan M Shokat
Journal:  PLoS Biol       Date:  2009-02-10       Impact factor: 8.029

10.  Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse.

Authors:  Sharon W Way; James McKenna; Ulrike Mietzsch; R Michelle Reith; Henry Cheng-Ju Wu; Michael J Gambello
Journal:  Hum Mol Genet       Date:  2009-01-15       Impact factor: 6.150

View more
  34 in total

Review 1.  mTOR signaling in epilepsy: insights from malformations of cortical development.

Authors:  Peter B Crino
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-01       Impact factor: 6.915

2.  Human GPRC6A Mediates Testosterone-Induced Mitogen-Activated Protein Kinases and mTORC1 Signaling in Prostate Cancer Cells.

Authors:  Ruisong Ye; Min Pi; Mohammed M Nooh; Suleiman W Bahout; L Darryl Quarles
Journal:  Mol Pharmacol       Date:  2019-03-20       Impact factor: 4.436

3.  mTOR as a potential treatment target for epilepsy.

Authors:  Michael Wong
Journal:  Future Neurol       Date:  2012-09-01

4.  Glucose transporter 3 performs a critical role in mTOR-mediated oncogenic glycolysis and tumorigenesis.

Authors:  Yanbin Zhang; Can Wei; Junhua Xi; Zhiguo Tang; Chaozhao Liang
Journal:  Oncol Lett       Date:  2015-03-26       Impact factor: 2.967

Review 5.  Mammalian target of rapamycin (mTOR) inhibition: potential for antiseizure, antiepileptogenic, and epileptostatic therapy.

Authors:  Robin C C Ryther; Michael Wong
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

6.  Deletion of mTOR in Reactive Astrocytes Suppresses Chronic Seizures in a Mouse Model of Temporal Lobe Epilepsy.

Authors:  Xueqin Wang; Longze Sha; Nannan Sun; Yan Shen; Qi Xu
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

Review 7.  Linking traumatic brain injury to chronic traumatic encephalopathy: identification of potential mechanisms leading to neurofibrillary tangle development.

Authors:  Brandon Peter Lucke-Wold; Ryan Coddington Turner; Aric Flint Logsdon; Julian Edwin Bailes; Jason Delwyn Huber; Charles Lee Rosen
Journal:  J Neurotrauma       Date:  2014-04-11       Impact factor: 5.269

Review 8.  Purines: forgotten mediators in traumatic brain injury.

Authors:  Edwin K Jackson; Detlev Boison; Michael A Schwarzschild; Patrick M Kochanek
Journal:  J Neurochem       Date:  2016-02-25       Impact factor: 5.372

Review 9.  A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials.

Authors:  Michael Wong
Journal:  Expert Rev Neurother       Date:  2013-06       Impact factor: 4.618

Review 10.  Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review.

Authors:  Martin J Brodie; Frank Besag; Alan B Ettinger; Marco Mula; Gabriella Gobbi; Stefano Comai; Albert P Aldenkamp; Bernhard J Steinhoff
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.